share_log

The Three-year Returns Have Been Splendid for Glaukos (NYSE:GKOS) Shareholders Despite Underlying Losses Increasing

The Three-year Returns Have Been Splendid for Glaukos (NYSE:GKOS) Shareholders Despite Underlying Losses Increasing

尽管其潜在损失增加,但Glaukos(纽交所:GKOS)的三年回报对股东来说一直是辉煌的。
Simply Wall St ·  11/26 19:35

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But when you pick a company that is really flourishing, you can make more than 100%. To wit, the Glaukos Corporation (NYSE:GKOS) share price has flown 225% in the last three years. How nice for those who held the stock! It's also up 9.5% in about a month. But this could be related to good market conditions -- stocks in its market are up 4.3% in the last month.

可能看起来很糟糕,但是当你买入股票(没有杠杆作用)时可能发生的最糟糕的情况是其股价降至零。但是,当你选择一家真正蓬勃发展的公司时,你的收入可以超过100%。换句话说,格劳科斯公司(纽约证券交易所代码:GKOS)的股价在过去三年中上涨了225%。对于那些持有股票的人来说真好!它在大约一个月内也上涨了9.5%。但这可能与良好的市场状况有关——其市场股票在上个月上涨了4.3%。

Since the stock has added US$328m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

由于该股仅在过去一周的市值就增加了3.28亿美元,因此让我们看看基础表现是否推动了长期回报。

Glaukos wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

在过去的十二个月中,Glaukos没有盈利,我们不太可能看到其股价与每股收益(EPS)之间存在很强的相关性。可以说,收入是我们的下一个最佳选择。一般而言,没有利润的公司预计每年收入将增长,而且速度很快。这是因为快速的收入增长可以很容易地推断出来预测利润,通常规模相当大。

Glaukos' revenue trended up 6.5% each year over three years. Considering the company is losing money, we think that rate of revenue growth is uninspiring. In comparison, the share price rise of 48% per year over the last three years is pretty impressive. Shareholders should be pretty happy with that, although interested investors might want to examine the financial data more closely to see if the gains are really justified. It seems likely that the market is pretty optimistic about Glaukos, given it is losing money.

Glaukos的收入在三年内每年增长6.5%。考虑到该公司正在亏损,我们认为收入增长率并不令人鼓舞。相比之下,在过去三年中,股价每年上涨48%,令人印象深刻。股东应该对此感到非常满意,尽管感兴趣的投资者可能希望更仔细地研究财务数据,看看收益是否真的合理。鉴于格劳科斯正在亏损,市场似乎对格劳科斯非常乐观。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下图显示了收入和收入在一段时间内的跟踪情况(如果你点击图片,你可以看到更多的细节)。

big
NYSE:GKOS Earnings and Revenue Growth November 26th 2024
纽约证券交易所:GKOS 收益和收入增长 2024 年 11 月 26 日

Glaukos is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So it makes a lot of sense to check out what analysts think Glaukos will earn in the future (free analyst consensus estimates)

Glaukos是一只知名股票,分析师报道丰富,这表明未来增长有一定的可见性。因此,看看分析师认为Glaukos未来的收入很有意义(免费的分析师共识估计)

A Different Perspective

不同的视角

It's nice to see that Glaukos shareholders have received a total shareholder return of 140% over the last year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 18% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. It's always interesting to track share price performance over the longer term. But to understand Glaukos better, we need to consider many other factors. Even so, be aware that Glaukos is showing 2 warning signs in our investment analysis , you should know about...

很高兴看到格劳科斯股东去年获得的股东总回报率为140%。由于一年期股东总回报率好于五年期股东总回报率(后者为每年18%),因此该股的表现似乎在最近有所改善。在最好的情况下,这可能暗示着一些真正的业务势头,这意味着现在可能是深入研究的好时机。长期跟踪股价表现总是很有意思的。但是为了更好地了解Glaukos,我们需要考虑许多其他因素。即便如此,请注意,Glaukos在我们的投资分析中显示了两个警告信号,您应该知道...

But note: Glaukos may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但请注意:Glaukos可能不是最好的买入股票。因此,来看看这份过去盈利增长(以及进一步增长预测)的有趣公司的免费清单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗?直接联系我们。或者,发送电子邮件给编辑组(网址为)simplywallst.com。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发